Willow Biosciences announces licensing partnership with Laurus Labs for production of high-value active pharmaceutical ingredients: Sunnyvale, California Saturday, June 1, 2024, 1 ...
Biogen receives European marketing authorization for Qalsody to treat a rare, genetic form of ALS: Cambridge, Massachusetts Saturday, June 1, 2024, 10:00 Hrs [IST] Biogen Inc. ann ...
Novartis phase III data confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria: Basel Saturday, June 1, 2024, 09:00 Hrs [IST] Novart ...
The Pharmaceuticals Export Promotion Council of India (Pharmexcil), in collaboration with Germany-based regulatory consultancy MT Promedt Consulting GmbH, is set to host a pivotal workshop on June 14, ...
Medical imaging is undergoing revolution due to advances in MRI & AI integration: Sathish Balakrishnan: Nandita Vijayasimha, Bengaluru Saturday, June 1, 2024, 08:00 Hrs [IST] Medi ...
India's is now a key hub for lifesciences Global Capability Centers (GCCs). This according to multinational majors like Amgen, GSK, Eli Lily, Bayer, Mylan, AstraZeneca among others indicated that it ...
First institution that started ‘chemist & druggist diploma course’ has no D Pharm course now: Peethaambaran Kunnathoor, Chennai Saturday, June 1, 2024, 08:00 Hrs [IST] Althoug ...
CDSCO releases updated version of guidance for PAC in biological products: Gireesh Babu, New Delhi Saturday, June 1, 2024, 08:00 Hrs [IST] The Central Drugs Standard Control Organ ...
Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO: San Diego Friday, May 31, 2024, 18:00 Hrs [IST] Illumina Inc., a ...
The Alwar Pharmacy College in Rajasthan has organized a one-day international conference in collaboration with ESIC Medical College and Hospital at Alwar on “Preventive healthcare and precision ...
Remedy Pharma announces results from pre-specified subgroup & post hoc analyses of phase 3 CHARM clinical trial of CIRARA: New York Friday, May 31, 2024, 15:00 Hrs [IST] Remedy Ph ...
Alentis Therapeutics receives US FDA orphan drug designation for monoclonal antibody lixudebart to treat IPF: Basel, Switzerland Friday, May 31, 2024, 14:00 Hrs [IST] Alentis Ther ...